摘要
非恶性呼吸疾病患者终末期遭受的呼吸困难、焦虑抑郁、厌食等症状负担与肺癌晚期患者同样严重,其缓和医疗需求不容忽视。但由于非恶性呼吸疾病发展轨迹不确定、预估生存期困难、缓和医疗转诊时机不明等原因,缓和医疗开展相对困难。为提高非恶性呼吸疾病患者终末期的生活质量,缓和医疗建议可使用阿片类药物治疗难治性呼吸困难,使用苯二氮卓类药物缓解焦虑抑郁;发挥多学科团队合作,提高专业缓和医疗能力,加强与患者照顾者的沟通。对于我国缓和医疗的发展,需要加大政府投入、加强团队建设、普及公众教育等。
Compared with lung cancer, the burden of dyspnea, anxiety, depression and anorexia in patients with non-malignant respiratory diseases are as serious as that in patients with advanced lung cancer, and their palliative care needs cannot be ignored. However, due to the uncertain track of the development of non-malignant respiratory diseases, difficulties in prediction for survival time and unknown timing of palliative care referrals, it is relatively difficult to carry out palliative care. In order to improve the quality of life of patients with non-malignant respiratory diseases, it is suggested that opioids can be used to treat refractory dyspnea and benzodiazepines can be used to relieve anxiety and depression. The multi-disciplinary team cooperation can be used to improve the professional palliative care and strengthen the communication between medical staff with the patients and caregivers. For the development of palliative care in China, it is necessary to increase government investment, strengthen the construction of palliative care team, and improve public education and so on.
作者
张馨予
万群芳
吴小玲
ZHANG Xin-yu;WAN Qun-fang;WU Xiao-ling(Department of Nursing,Chengdu BOE Hospital,Chengdu 610041,China)
出处
《医学与哲学》
2019年第20期30-34,共5页
Medicine and Philosophy
关键词
缓和医疗
肺癌
非恶性呼吸疾病
palliative care
lung cancer
non-malignant respiratory diseases
